B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Erythropoietin activates STAT5

REACTOME PATHWAY
Reactome: R-HSA-90272833 genes21 compounds

The Erythropoietin activates STAT5 pathway (Reactome ID: R-HSA-9027283) involves 3 genes and is affected by 21 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

JAK2LYNSTAT5A

Compounds Affecting Erythropoietin activates STAT5

#CompoundTargets HitStudies
1Dasatinib299
2Sorafenib300
3Azauridine300
4Cladribine297
5Methylene Blue200
62-Methoxyestradiol300
7Astemizole Antihistamine drug now withdrawn from280
8Azathioprine300
9Calcitriol300
10Camptothecin300
11Cytarabine297
12dihydrorotenone13
13Podophyllotoxin14
14streptonigrin299
15Trifluridine295
16Tripterygium300
17tyrphostin ag 14784
18alsterpaullone12
19Crizotinib298
20kenpaullone8
21sp600125117

About the Erythropoietin activates STAT5 Pathway

The Erythropoietin activates STAT5 pathway is catalogued in Reactome (ID: R-HSA-9027283) and involves 3 genes. In the BiohacksAI corpus, 21 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include JAK2, LYN, STAT5A.